United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Gilead’s EVOKE-02 study of Trodelvy, KEYTRUDA combo shows promise in NSCLC Gilead Sciences, Inc. announced early data showcasing promising clinical activity of Trodelvy in combination with Merck’s KEYTRUDA for… byPallavi MadhirajuSeptember 10, 2023